Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The history now includes a new Revision: v3.6.6 entry, replacing the previous Revision: v3.6.5. This reflects a minor metadata update to the page’s version history on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-08-30T00:42:29.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The history shows a new site revision (v3.6.5) was added and the previous revision (v3.6.4) was removed, reflecting a minor system update.
    Difference
    0.1%
    Check dated 2026-08-08T23:37:43.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new version entry, Revision: v3.6.4, appears in the history, replacing the prior Revision: v3.6.3. This reflects a minor update to the record's versioning on the page.
    Difference
    0.1%
    Check dated 2026-07-25T17:12:14.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new release entry, Revision: v3.6.3, has been added to the study record's version history, following the previous Revision: v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-04T04:52:50.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The study history now includes a new revision entry v3.6.2 and removes the older v3.6.0 from the visible history. This updates the version record shown on the page.
    Difference
    0.1%
    Check dated 2026-06-27T03:23:07.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The study is no longer looking for participants, indicating enrollment has halted. The history also shows a new revision labeled v3.6.0 and the previous revision v3.5.5 has been removed from the record history.
    Difference
    0.6%
    Check dated 2026-06-12T17:23:54.000Z thumbnail image

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.